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Background: Autosomal dominant polycystic kidney disease (ADPKD) is characterized
by renal cyst formation due to mutations in genes coding for polycystin-1 [PKD1 (85–90%
of cases), on ch 16p13.3] and polycystin-2 [PKD2 (10–15% of cases), on ch 4q13-23]
and PKD3 gene (gene unmapped). It is also associated with TSC2/PKD1 contiguous
gene syndrome. ADPKD is usually inherited, but new mutations without a family history
occur in approximately 10% of the cases.
Case presentation: A 17-year-old boy was followed up for bilateral cystic kidney
disease, hypertension, and obesity since he was 13 years old. The diagnosis was an acci-
dental finding during abdominal CT at age 13 to rule out appendicitis. A renal ultrasono-
gram also demonstrated a multiple bilateral cysts. Because of parental history of bilateral
renal cysts, PKD1 and PKD2, genetic testing was ordered. Results showed, PKD2 variant
1:3 bp deletion of TGT; nucleotide position: 1602–1604; codon position: 512–513; mRNA
reading frame maintained. The same mutation was later identified in his father.
Conclusion: A smaller number of patients have a defect in the PKD2 locus on chromo-
some 4 (resulting in PKD2 disease). There are no known published cases on this familiar
genetic variant of ADPKD-2 cystic kidney disease. In this case, the disease is present
unusually early in life.
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Background
Autosomal dominant polycystic kidney disease (ADPKD) is an autosomal dominant renal cyst
disorder due to mutations in genes coding for polycystin-1 (PKD1, on ch 16p13.3) and polycystin-
2 (PKD2, on ch 4q13-23) and PKD3 gene (gene unmapped). It is also associated with TSC2/PKD1
contiguous gene syndrome. ADPKD is usually inherited, but newmutations without a family history
occur in approximately 10% of the cases. Here, we describe a case of new genetic mutation, which
causes a disease early in life.
Case Report
A 17-year-old boy was followed up by pediatric nephrologist for bilateral cystic kidney disease,
hypertension, and obesity since he was 13 years old. The diagnosis was an accidental finding during
abdominal CT at the age of 13 to rule out appendicitis (BUN, 14; Cr, 0.77; electrolytes, WNL).
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Ultrasonogram Finding
At the age of 14, the right kidney measured 11.3 cm 5.2 cm
(Figure 1), and the left kidney measured 11.2 cm 5.2 cm.
There was a cluster of cysts about the upper pole of the
right kidney measuring 2.4 cm 1.9 cm 3.4 cm and identified
cysts about the mid pole region of the right kidney measur-
ing 1.9 cm 1.6 cm 1.7 cm and 1.7 cm 1.2 cm 2.3 cm. There
was a cyst about the mid to lower pole region of the left kidney
measuring 1.7 cm 1.4 cm 2.0 cm. No hydronephrosis and a
good corticomedullary differentiation were observed. At the age
of 17, during follow up, renal ultrasound examination was done.
The right kidney measured 11.0 cm 6.1 cm, and the left kidney
measured 11.1 cm 6.0 cm. There were bilateral cysts, some of
which increased in size (2.9 cm 2.4 cm 3.1 cm) slightly since
the last renal ultrasound examination.
Impression
Bilateral renal cysts are shown in Figures 1A,B. Because of
parental history of bilateral renal cysts, PKD1 and PKD2, genetic
testing [familial juvenile nephronophthisis (FJN);Molecular Eval-
uation] was ordered. This targeted analysis was conducted to
determine whether the DNA variants identified in another family
member are present in this individual.
Results
Results showed that PKD2 variant 1:3 bp deletion of TGT;
nucleotide position: 1602–1604; codon position: 512–513; mRNA
reading frame maintained. Later, a parental genetic testing
was performed and showed the same mutation PKD2 variant
c.1602_1604 3 bp deletion of TGT. There is currently no known
published research on this variant.
Discussion
The occurrence of ADPKD is 1 case per 200–1000 people. Six
to ten percent of cases of end-stage renal disease in Europe and
USA occur due to this medical condition. ADPKD disease is often
present later in life (1). Genetic defects responsible for ADPKD
includes, but not limited to, frameshift, deletion, and missense
mutations. The most frequent anomaly is on chromosome 16 in
the PKD1 locus that is linked to the alpha-globin gene (85–90%
of cases) (2). The other frequent defect is in the PKD2 locus
on chromosome 4 (10% of cases). A few families have a defect
unrelated to either locus (3–5). PKD1 and PKD2 encode proteins
called polycystin-1 and polycystin-2 (6–12).
PKD1 is a large and composite gene (46 exons) that produces
a 14-kb mRNA and encodes protein of over 4000 amino acids
in length (7, 8, 11, 13). On the other hand, PKD-2 is smaller
(15 exons) and encodes a protein less than 1000 amino acids in
length (11). Mutated proteins are involved in cell differentiation,
polarization, proliferation, andmembrane transport. Polycystin-1
is localized not only in renal tubular epithelia but also in hepatic
bile ductules and pancreatic ducts, leading to cyst formation. It is
an integral membrane protein, which is found primarily in plasma
membranes but also in the primary cilium and less abundant in
adult than fetal epithelia. It is overexpressed in most, but not
all, cysts in kidneys from patients with ADPKD and involved in
adhesive protein–protein, cell–cell, and cell–matrix interactions
(7, 14).
Polycystin-2 is involved in cell calcium signaling (9, 12). PKD2
gene product is expressed in the distal tubules, collecting duct,
and thick ascending limb in normal fetal and adult kidneys.
It localizes to the endoplasmic reticulum and not the plasma
membrane localized to the primary cilium. Polycystin-1 and
polycystin-2 are expressed in similar cellular and subcellular loca-
tions, although the overlap is not uniform. Polycystin-1 appears
to activate the JAK–STAT pathway, thereby inducing cell cycle
arrest (15).
The exact mechanism of cyst formation is not yet understood
(16). Abnormalities in renal cilia from mutations in either gene
may contribute to renal cyst formation, as PKD1 and PKD2
localize to renal cilia (9). Cysts form in all regions of the nephron,
enlarging and expanding throughout life. Normal renal function
is maintained until mid-adulthood in most patients.
FIGURE 1 | Bilateral renal cysts: (A) right kidney and (B) left kidney. At the age of 14, the right kidney measured 11.3 cm5.2 cm, and the left kidney
measured 11.2 cm5.2 cm. There was a cluster of cysts about the upper pole of the right kidney measuring 2.4 cm1.9 cm3.4 cm and identified cysts about
the mid pole region of the right kidney measuring 1.9 cm1.6 cm1.7 cm and 1.7 cm1.2 cm2.3 cm. There was a cyst about the mid to lower pole region of
the left kidney measuring 1.7 cm1.4 cm2.0 cm. No hydronephrosis and a good corticomedullary differentiation were observed.
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DNA analysis is the gold standard for the diagnosis of ADPKD-
2 because ultrasound is not reliable till a patient is young (17). This
is a case of new familiar genetic mutation of PKD2 that probably
causes a development of ADPKD in this patient during childhood.
Conclusion
A smaller number of patients have a defect in the PKD2
locus on chromosome 4 (resulting in PKD2 disease), and a
few families have an undefined defect. In this case, the same
familiar genetic mutation was identified. There are no known
published cases on this genetic variant of ADPKD-2 cystic kidney
disease. In this case, the disease is present unusually early in
life.
Patient Consent
The patient gave consent for this case report to be published.
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